18F-FDG PET biomarker of individual cerebral metabolic connectivity in focal epilepsy subtypes and association with prognosis - Report - MDSpire

18F-FDG PET biomarker of individual cerebral metabolic connectivity in focal epilepsy subtypes and association with prognosis

  • By

  • Li Li Liu

  • Zhen Peng Chen

  • Zhehao Lyu

  • Dongxue Wang

  • Bing Han

  • Ping Li

  • June 16, 2026

  • 0 min

Share

Clinical Report: Assessment of 18F-FDG PET in Focal Epilepsy Variations

Overview

This study investigates the topological alterations in metabolic connectivity in patients with focal epilepsy, specifically right temporal lobe epilepsy (RTLE), left temporal lobe epilepsy (LTLE), and extra temporal lobe epilepsy (ETLE). Significant differences in metabolic network connectivity were observed compared to healthy controls, with implications for prognosis in ETLE patients.

Background

Focal epilepsy is a prevalent neurological condition affecting millions globally, often linked to structural brain lesions. Understanding the metabolic connectivity variations in different subtypes of focal epilepsy can enhance diagnostic accuracy and inform treatment strategies. The use of 18F-FDG PET as a biomarker for assessing these variations is crucial for improving patient outcomes.

Data Highlights

GroupKey Disparity Nodes
RTLERight Rolandic area, Bilateral cerebellum, Left superior parietal gyrus
LTLELeft middle temporal gyrus, Right fusiform gyrus, Left thalamus, Right calcarine area
ETLEUnilateral postcentral gyrus, Bilateral supramarginal gyrus, Right thalamus, Caudate

Key Findings

  • RTLE, LTLE, and ETLE patients showed significant alterations in metabolic network connectivity compared to healthy controls (p < 0.01, FDR-corrected).
  • Distinct nodes of disparity were identified for each epilepsy subtype, indicating unique metabolic connectivity patterns.
  • In ETLE patients, certain edge connectivity metrics correlated positively with prognosis classifications.
  • 18F-FDG PET serves as an informative tool for identifying potential epileptic zones in conjunction with MRI findings.
  • The study highlights the importance of metabolic connectivity in understanding the clinical symptomatology of focal epilepsy.

Clinical Implications

The findings suggest that 18F-FDG PET can be utilized to assess metabolic connectivity variations in focal epilepsy, which may aid in prognosis and treatment planning. Clinicians should consider integrating metabolic connectivity data with structural imaging for comprehensive patient evaluations.

Conclusion

This research underscores the distinct metabolic network characteristics in focal epilepsy subtypes, providing a foundation for future studies on imaging-based biomarkers and their clinical relevance.

Related Resources & Content

  1. Journal of Neuro-Oncology, 2022 -- Radiomic Analysis of Static FET PET Imaging for Distinguishing Treatment-Induced Changes from Glioma Advancement
  2. Journal of Neuro-Oncology, 2022 -- Utilization and Future Directions of PET Imaging in Patients Diagnosed with IDH-Mutated Gliomas
  3. Journal of Neuro-Oncology, 2022 -- Utilization of [18F]fluorodopa PET Imaging for Glioma Grading
  4. Journal of Gastroenterology, 2013 -- Utilization of 18F-fluorodeoxyglucose PET Imaging for Post-Treatment Evaluation of Malignant Liver Tumors
  5. Society of Nuclear Medicine, 2025 -- SNMMI/EANM Guidelines for FDG Brain PET
  6. Surgical targeting of lateralized 18F-fluorodeoxyglucose positron emission tomography hypometabolism relates to long-term epilepsy surgery outcomes, 2023
  7. Current Practice Standards for 18F-FDG PET in Epilepsy
  8. Outcome-focused Evidence on FDG-PET Metrics in Epilepsy Surgery
  9. Preserved ictal responsiveness in right mesial temporal lobe epilepsy: metabolic correlates in posterior temporal networks with FDG-PET

Original Source(s)

Related Content